These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 20087880)

  • 1. K-ras exon 4A has a tumour suppressor effect on carcinogen-induced murine colonic adenoma formation.
    Luo F; Ye H; Hamoudi R; Dong G; Zhang W; Patek CE; Poulogiannis G; Arends MJ
    J Pathol; 2010 Apr; 220(5):542-50. PubMed ID: 20087880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant K-ras promotes carcinogen-induced murine colorectal tumourigenesis, but does not alter tumour chromosome stability.
    Luo F; Poulogiannis G; Ye H; Hamoudi R; Zhang W; Dong G; Arends MJ
    J Pathol; 2011 Feb; 223(3):390-9. PubMed ID: 21171084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutationally activated K-ras 4A and 4B both mediate lung carcinogenesis.
    Patek CE; Arends MJ; Wallace WA; Luo F; Hagan S; Brownstein DG; Rose L; Devenney PS; Walker M; Plowman SJ; Berry RL; Kolch W; Sansom OJ; Harrison DJ; Hooper ML
    Exp Cell Res; 2008 Mar; 314(5):1105-14. PubMed ID: 18062963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pro-apoptotic K-Ras 4A proto-oncoprotein does not affect tumorigenesis in the ApcMin/+ mouse small intestine.
    Patek CE; Arends MJ; Rose L; Luo F; Walker M; Devenney PS; Berry RL; Lawrence NJ; Ridgway RA; Sansom OJ; Hooper ML
    BMC Gastroenterol; 2008 Jun; 8():24. PubMed ID: 18554389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wild-type K-ras has a tumour suppressor effect on carcinogen-induced murine colorectal adenoma formation.
    Luo F; Poulogiannis G; Ye H; Hamoudi R; Dong G; Zhang W; Ibrahim AE; Arends MJ
    Int J Exp Pathol; 2014 Feb; 95(1):8-15. PubMed ID: 24354449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The K-Ras 4A isoform promotes apoptosis but does not affect either lifespan or spontaneous tumor incidence in aging mice.
    Plowman SJ; Arends MJ; Brownstein DG; Luo F; Devenney PS; Rose L; Ritchie AM; Berry RL; Harrison DJ; Hooper ML; Patek CE
    Exp Cell Res; 2006 Jan; 312(1):16-26. PubMed ID: 16271715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice.
    Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
    Oncogene; 2007 Jun; 26(30):4415-27. PubMed ID: 17297472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
    Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
    Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-ras 4A and 4B are co-expressed widely in human tissues, and their ratio is altered in sporadic colorectal cancer.
    Plowman SJ; Berry RL; Bader SA; Luo F; Arends MJ; Harrison DJ; Hooper ML; Patek CE
    J Exp Clin Cancer Res; 2006 Jun; 25(2):259-67. PubMed ID: 16918139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism between K-rasVal12 and mutant Apc accelerates murine large intestinal tumourigenesis.
    Luo F; Poulogiannis G; Ye H; Hamoudi R; Arends MJ
    Oncol Rep; 2011 Jul; 26(1):125-33. PubMed ID: 21573497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras.
    Wislez M; Spencer ML; Izzo JG; Juroske DM; Balhara K; Cody DD; Price RE; Hittelman WN; Wistuba II; Kurie JM
    Cancer Res; 2005 Apr; 65(8):3226-35. PubMed ID: 15833854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
    Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
    Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary supplementation of lutein reduces colon carcinogenesis in DMH-treated rats by modulating K-ras, PKB, and β-catenin proteins.
    Reynoso-Camacho R; González-Jasso E; Ferriz-Martínez R; Villalón-Corona B; Loarca-Piña GF; Salgado LM; Ramos-Gomez M
    Nutr Cancer; 2011; 63(1):39-45. PubMed ID: 21128180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
    Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
    Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis.
    Boparai KS; Dekker E; Van Eeden S; Polak MM; Bartelsman JF; Mathus-Vliegen EM; Keller JJ; van Noesel CJ
    Gastroenterology; 2008 Dec; 135(6):2014-8. PubMed ID: 19013464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation.
    Kim H; Yang XL; Rosada C; Hamilton SR; August JT
    Arch Biochem Biophys; 1994 May; 310(2):504-7. PubMed ID: 7513984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
    Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
    Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis.
    Ward RL; Todd AV; Santiago F; O'Connor T; Hawkins NJ
    Cancer; 1997 Mar; 79(6):1106-13. PubMed ID: 9070487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-ras proto-oncogene exhibits tumor suppressor activity as its absence promotes tumorigenesis in murine teratomas.
    James RM; Arends MJ; Plowman SJ; Brooks DG; Miles CG; West JD; Patek CE
    Mol Cancer Res; 2003 Sep; 1(11):820-5. PubMed ID: 14517344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. While K-ras is essential for mouse development, expression of the K-ras 4A splice variant is dispensable.
    Plowman SJ; Williamson DJ; O'Sullivan MJ; Doig J; Ritchie AM; Harrison DJ; Melton DW; Arends MJ; Hooper ML; Patek CE
    Mol Cell Biol; 2003 Dec; 23(24):9245-50. PubMed ID: 14645534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.